{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:03:07Z","timestamp":1785740587414,"version":"3.56.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bpobgyn.2022.02.001","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T11:59:47Z","timestamp":1644407987000},"page":"12-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Clinical tools and counseling considerations for breast cancer risk assessment and evaluation for hereditary cancer risk"],"prefix":"10.1016","volume":"82","author":[{"given":"Lauren E.","family":"Hipp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey B.","family":"Hulswit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara J.","family":"Milliron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2022.02.001_bib1","series-title":"Cancer facts & figures 2021","year":"2021"},{"key":"10.1016\/j.bpobgyn.2022.02.001_bib2","series-title":"Risk factors for breast cancer | breast cancer | cancer research UK","year":"2020"},{"key":"10.1016\/j.bpobgyn.2022.02.001_bib3","series-title":"Breast cancer","year":"2021"},{"issue":"9","key":"10.1016\/j.bpobgyn.2022.02.001_bib4","article-title":"Association of population screening for breast cancer risk with use of mammography among women in medically underserved racial and ethnic minority groups","volume":"4","author":"Schwartz","year":"2021","journal-title":"J\u00a0Am Med Assoc Netw Open"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.02.001_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.breast.2012.12.005","article-title":"Perceived risk and adherence to breast cancer screening guidelines among women with a familial history of breast cancer: a review of the literature","volume":"22","author":"Walker","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.bpobgyn.2022.02.001_bib6","series-title":"SEER\u2217Stat database: SEER incidence and U.S. Death rates, age-adjusted and age-specific rates, by race and sex","year":"2013"},{"issue":"7","key":"10.1016\/j.bpobgyn.2022.02.001_bib7","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1245\/s10434-010-1468-3","article-title":"Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration","volume":"18","author":"Gnerlich","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bpobgyn.2022.02.001_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mds187","article-title":"Triple-negative breast cancer: epidemiological considerations and recommendations","volume":"23","author":"Boyle","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.02.001_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrc3896","article-title":"Triple-negative breast cancer in African-American women: disparities versus biology","volume":"15","author":"Dietze","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.bpobgyn.2022.02.001_bib10","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1245\/s10434-017-5977-1","article-title":"Breast cancer disparities: socioeconomic factors versus biology","volume":"24","author":"Newman","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"239","key":"10.1016\/j.bpobgyn.2022.02.001_bib11","article-title":"Oestrogen exposure and breast cancer risk","volume":"5","author":"Travis","year":"2003","journal-title":"Breast Cancer Res"},{"issue":"5","key":"10.1016\/j.bpobgyn.2022.02.001_bib12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ijc.2910460508","article-title":"Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study","volume":"46","author":"Hsieh","year":"1990","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.bpobgyn.2022.02.001_bib13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/aje\/152.10.950","article-title":"Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the nurses' health study","volume":"152","author":"Colditz","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2022.02.001_bib14","first-page":"567","article-title":"Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus","volume":"4","author":"Colditz","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9328","key":"10.1016\/j.bpobgyn.2022.02.001_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(02)09454-0","article-title":"Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancer and 96,973 women without the disease","volume":"360","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.bpobgyn.2022.02.001_bib16","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/annonc\/mdv379","article-title":"Breastfeeding and breast cancer risk by receptor status\u2014a systematic review and meta-analysis","volume":"26","author":"Islami","year":"2015","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.02.001_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women's Health Initiative Randomized Clinical Trials","volume":"324","author":"Chlebowski","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-018-0967-1","article-title":"Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape","volume":"20","author":"Kader","year":"2018","journal-title":"Breast Cancer Res"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.02.001_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejso.2011.01.009","article-title":"Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast\u2013a review","volume":"37","author":"Hussain","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast \u2014 risk assessment and management options","volume":"372","author":"Hartmann","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-012-2318-8","article-title":"The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions","volume":"136","author":"Coopey","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.02.001_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cncr.22408","article-title":"Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia","volume":"109","author":"Collins","year":"2007","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.02.001_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.mayocp.2013.12.014","article-title":"Breast density and breast cancer risk: a practical review","volume":"89","author":"Wang","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.02.001_bib24","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","article-title":"Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis","volume":"15","author":"McCormack","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1148\/radiol.13131217","article-title":"The California breast density information group: a collaborative response to the issues of breast density, breast cancer risk, and breast density notification legislation","volume":"269","author":"Price","year":"2013","journal-title":"Radiol"},{"issue":"24","key":"10.1016\/j.bpobgyn.2022.02.001_bib26","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1200\/JCO.2009.26.4770","article-title":"Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use","volume":"28","author":"Kerlikowske","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"J\u00a0Am Med Assoc"},{"issue":"9","key":"10.1016\/j.bpobgyn.2022.02.001_bib28","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.7314\/APJCP.2013.14.9.4965","article-title":"Alcohol consumption and risk of cancer: a systematic literature review","volume":"14","author":"de Menezes","year":"2013","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"11","key":"10.1016\/j.bpobgyn.2022.02.001_bib29","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.bjc.6600596","article-title":"Alcohol, tobacco and breast cancer \u2013 collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease","volume":"87","author":"Hamajima","year":"2002","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/alcalc\/ags011","article-title":"Epidemiology and pathophysiology of alcohol and breast cancer: update 2012","volume":"47","author":"Seitz","year":"2012","journal-title":"Alcohol Alcohol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2022.02.001_bib31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/aje\/kwv092","article-title":"Smoking and risk of breast cancer in a racially\/ethnically diverse population of mainly women who do not drink alcohol","volume":"182","author":"Gram","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.02.001_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/archinternmed.2010.503","article-title":"Cigarette smoking and the incidence of breast cancer","volume":"171","author":"Xue","year":"2011","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.bpobgyn.2022.02.001_bib33","first-page":"2207","article-title":"A\u00a0prospective study of smoking and breast cancer risk among African-American women","volume":"24","author":"Rosenberg","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.bpobgyn.2022.02.001_bib34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrc1608","article-title":"The nurses' health study: lifestyle and health among women","volume":"5","author":"Colditz","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.02.001_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3322\/caac.21591","article-title":"American Cancer Society guideline for diet and physical activity for cancer prevention","volume":"70","author":"Rock","year":"2020","journal-title":"Cancer J Clin"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.soc.2014.03.011","article-title":"Epidemiology of breast cancer","volume":"23","author":"Ban","year":"2014","journal-title":"Surg Oncol N Am"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-017-4325-2","article-title":"Family history and risk of breast cancer: an analysis accounting for family structure","volume":"165","author":"Brewer","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib38","first-page":"441","article-title":"Family history: the three-generation pedigree","volume":"72","author":"Wattendorf","year":"2005","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/AOG.0b013e318214780e","article-title":"478: family history as a risk assessment tool","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2022.02.001_bib40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10897-008-9169-9","article-title":"Standardized human pedigree nomenclature: update and assessment of the recommendations of the National Society of Genetic counselors","volume":"17","author":"Bennett","year":"2008","journal-title":"J\u00a0Genet Counsel"},{"key":"10.1016\/j.bpobgyn.2022.02.001_bib41","series-title":"About the calculator","year":"2021"},{"issue":"21","key":"10.1016\/j.bpobgyn.2022.02.001_bib42","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/jnci\/91.21.1829","article-title":"Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer","volume":"91","author":"Gail","year":"1999","journal-title":"J\u00a0Natl Cancer Inst (Bethesda)"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.02.001_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.6004\/jnccn.2003.0027","article-title":"Breast cancer risk assessment: a guide for clinicians using the NCCN breast cancer risk reduction guidelines","author":"Merajver","year":"2003","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.02.001_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3322\/caac.20143","article-title":"Cancer screening in the United States, 2012","volume":"62","author":"Smith","year":"2012","journal-title":"Cancer J Clin"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","article-title":"Autosomal dominant inheritance of early-onset breast cancer. implications for risk prediction","volume":"73","author":"Claus","year":"1994","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.bpobgyn.2022.02.001_bib46","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1001\/jama.1985.03350370104033","article-title":"Family history and the risk of breast cancer","volume":"253","author":"Sattin","year":"1985","journal-title":"J\u00a0Am Med Assoc"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.02.001_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"Cancer J Clin"},{"issue":"23","key":"10.1016\/j.bpobgyn.2022.02.001_bib48","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A\u00a0breast cancer prediction model incorporating familial and personal risk factors","volume":"15","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.bpobgyn.2022.02.001_bib49","series-title":"IBIS breast cancer risk evaluation tool","author":"Cuzick","year":"2017"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib50","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1245\/s10434-019-07814-w","article-title":"The tyrer\u2013cuzick model inaccurately predicts invasive breast cancer risk in women with LCIS","volume":"27","author":"Valero","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2022.02.001_bib51","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","article-title":"BADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"Lee","year":"2019","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1158\/1055-9965.EPI-20-1319","article-title":"CanRisk tool\u2014a web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants","volume":"30","author":"Carver","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.02.001_bib53","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/1940-6207.CAPR-10-0076","article-title":"Update of the National Surgical Adjuvant Breast and Bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer","volume":"3","author":"Vogel","year":"2010","journal-title":"Cancer Prev Res"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14737140.9.1.51","article-title":"The NSABP study of tamoxifen and raloxifene (STAR) trial","volume":"9","author":"Vogel","year":"2009","journal-title":"Expet Rev Anticancer Ther"},{"issue":"25","key":"10.1016\/j.bpobgyn.2022.02.001_bib55","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.bpobgyn.2022.02.001_bib56","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1200\/JCO.2005.05.4882","article-title":"Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17","volume":"24","author":"Perez","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2022.02.001_bib57","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","article-title":"Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230","volume":"6","author":"Eastell","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib58","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-010-1121-7","article-title":"Reversal of skeletal effects of endocrine treatments in the intergroup exemestane study","volume":"124","author":"Coleman","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"17","key":"10.1016\/j.bpobgyn.2022.02.001_bib59","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.ejca.2006.07.005","article-title":"Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study","volume":"42","author":"Geisler","year":"2006","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.bpobgyn.2022.02.001_bib60","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/cncr.20971","article-title":"Screening women at high risk for breast cancer with mammography and magnetic resonance imaging","volume":"103","author":"Lehman","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.02.001_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1148\/radiol.2442060461","article-title":"Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study","volume":"244","author":"Lehman","year":"2007","journal-title":"Radiol"},{"issue":"41","key":"10.1016\/j.bpobgyn.2022.02.001_bib62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/jncimonographs\/lgq030","article-title":"Magnetic resonance imaging in the evaluation of ductal carcinoma in situ","volume":"2010","author":"Lehman","year":"2010","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1148\/radiology.211.1.r99ap38101","article-title":"Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?","volume":"211","author":"Kuhl","year":"1999","journal-title":"Radiol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib64","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jmri.26985","article-title":"Role of breast MRI in the evaluation and detection of DCIS: opportunities and challenges","volume":"52","author":"Greenwood","year":"2019","journal-title":"J\u00a0Magn Reson Imag"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/s40064-015-0793-1","article-title":"Comparison of false positive rates for screening breast magnetic resonance imaging (MRI) in high risk women performed on stacked versus alternating schedules","volume":"4","author":"Othman","year":"2015","journal-title":"SpringerPlus"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.02.001_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer","volume":"340","author":"Hartmann","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.02.001_bib67","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","article-title":"Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review","volume":"212","author":"Ludwig","year":"2016","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.02.001_bib68","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10689-010-9348-3","article-title":"Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PennII model to previous study","volume":"9","author":"Lindor","year":"2010","journal-title":"Fam Cancer"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib69","article-title":"Selecting a BRCA risk assessment model for use in a familial cancer clinic","volume":"9","author":"Panchal","year":"2008","journal-title":"BioMed Centr Med Gen"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.02.001_bib70","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1200\/PO.19.00360","article-title":"Development and validation of a clinical polygenic risk score to predict breast cancer risk","author":"Hughes","year":"2020","journal-title":"J\u00a0Clin Oncol Precis Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic risk scores for prediction of breast cancer and breast cancer subtypes","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.bpobgyn.2022.02.001_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002644","article-title":"Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: a nested case\u2013control Study","volume":"15","author":"Zhang","year":"2018","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.02.001_bib73","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng.2582","article-title":"Public health implications from cogs and potential for risk stratification and screening","volume":"45","author":"Burton","year":"2013","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.bpobgyn.2022.02.001_bib74","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/bjc.2011.118","article-title":"Polygenic susceptibility to prostate and breast cancer: implications for personalised screening","volume":"104","author":"Pashayan","year":"2011","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib75","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10549-016-3953-2","article-title":"Breast cancer risk prediction using a clinical risk model and polygenic risk score","volume":"159","author":"Shieh","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.bpobgyn.2022.02.001_bib76","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","article-title":"The personal and clinical utility of polygenic risk scores","volume":"19","author":"Torkamani","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"7","key":"10.1016\/j.bpobgyn.2022.02.001_bib77","article-title":"Association of a polygenic risk score with breast cancer among women carriers of high- and moderate-risk breast cancer genes","volume":"3","author":"Gallagher","year":"2020","journal-title":"J\u00a0Am Med Assoc Net Open"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.02.001_bib78","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin","year":"2019","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib79","doi-asserted-by":"crossref","first-page":"513","DOI":"10.18865\/ed.29.3.513","article-title":"Perspective: the clinical use of polygenic risk scores: race, ethnicity, and health disparities","volume":"29","author":"Roberts","year":"2019","journal-title":"Ethn Dis"},{"key":"10.1016\/j.bpobgyn.2022.02.001_bib80","series-title":"Breast cancer risk reduction","author":"Bevers","year":"2021"},{"issue":"12","key":"10.1016\/j.bpobgyn.2022.02.001_bib81","first-page":"1579","article-title":"Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women","volume":"11","author":"Thompson","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib82","article-title":"Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review","volume":"17","author":"Hann","year":"2017","journal-title":"BioMed Centr Pub Health"},{"issue":"23","key":"10.1016\/j.bpobgyn.2022.02.001_bib83","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/jnci\/djm223","article-title":"Projecting individualized absolute invasive breast cancer risk in African American women","volume":"99","author":"Gail","year":"2007","journal-title":"J\u00a0Natl Cancer Inst (Bethesda)"},{"issue":"12","key":"10.1016\/j.bpobgyn.2022.02.001_bib84","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/jnci\/djr154","article-title":"Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women","volume":"103","author":"Matsuno","year":"2011","journal-title":"J\u00a0Natl Cancer Inst (Bethesda)"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.02.001_bib85","article-title":"Projecting individualized absolute invasive breast cancer risk in US Hispanic women","volume":"109","author":"Banegas","year":"2016","journal-title":"J\u00a0Natl Cancer Inst (Bethesda)"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib86","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/1055-9965.EPI-12-0570","article-title":"Which risk model to use? clinical implications of the ACS MRI screening guidelines","volume":"22","author":"Ozanne","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"18","key":"10.1016\/j.bpobgyn.2022.02.001_bib87","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study","volume":"90","author":"Fisher","year":"1998","journal-title":"J\u00a0Natl Cancer Inst (Bethesda)"},{"issue":"11","key":"10.1016\/j.bpobgyn.2022.02.001_bib88","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/cncr.21030","article-title":"Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma","volume":"103","author":"Grann","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2022.02.001_bib89","series-title":"Counseling about cancer: strategies for genetic counseling","author":"Schneider","year":"2012"},{"issue":"15","key":"10.1016\/j.bpobgyn.2022.02.001_bib90","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1001\/jama.1993.03500150082032","article-title":"Genetic counseling for families with inherited susceptibility to breast and ovarian cancer","volume":"269","author":"Biesecker","year":"1993","journal-title":"J\u00a0Am Med Assoc"},{"issue":"S3","key":"10.1016\/j.bpobgyn.2022.02.001_bib91","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3+<576::AID-CNCR7>3.0.CO;2-7","article-title":"Genetic counseling and hereditary cancer","volume":"80","author":"Peters","year":"1997","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.02.001_bib92","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10897-005-9014-3","article-title":"A\u00a0new definition of genetic counseling: national Society of Genetic Counselors' task force report","volume":"15","author":"Resta","year":"2006","journal-title":"J\u00a0Genet Counsel"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.02.001_bib93","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10549-009-0375-4","article-title":"Accuracy of self-reported breast cancer among women undergoing mammography","volume":"118","author":"Abraham","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"10.1016\/j.bpobgyn.2022.02.001_bib94","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.297.23.2587","article-title":"Limited family structure and BRCA gene mutation status in single cases of breast cancer","volume":"297","author":"Weitzel","year":"2007","journal-title":"J\u00a0Am Med Assoc"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib95","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A\u00a0practice guideline from the American college of medical genetics and genomics and the national society of genetic counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2019","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.02.001_bib96","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/pch\/8.1.42","article-title":"Guidelines for genetic testing of healthy children","volume":"8","year":"2003","journal-title":"Paediatr Child Health"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693422000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693422000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:13:55Z","timestamp":1761498835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693422000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":96,"alternative-id":["S1521693422000232"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2022.02.001","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical tools and counseling considerations for breast cancer risk assessment and evaluation for hereditary cancer risk","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2022.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}